DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS (Details) $ in Thousands	Jun. 30, 2025 USD ($)	Dec. 31, 2024 USD ($)	Jul. 31, 2023 participant	Jun. 30, 2023 patient participant
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Accumulated deficit | $	$ 394,873	$ 325,127
Working capital | $	$ 123,500	$ 150,700
Number of patients enrolled in trail | patient				65
Number of patients enrolled in trial with one dose of study drug received | participant				62
Number of participants enrolled in trial with one dose of study drug received with primary and secondary objectives met | participant			62